Pal-GHK
Cosmetic peptide
A fat-modified version of the GHK tripeptide used in skincare. Human data comes mainly from tests of complete formulations.
SNAP-8
Also cited in the literature as Acetyl octapeptide-3
An eight-amino-acid peptide used in cosmetic formulations. Published evidence is mostly laboratory work and manufacturer testing.
Regulatory status: Not licensed as a medicine in the United Kingdom. It holds no MHRA marketing authorisation, has no approved indication, and is not approved for human or animal use.
Cell & tissue research
Research stage: Cosmetic ingredient testing; little independent research
Cells
Animal studies
Human trials
The research pathway — not every compound has reached human trials. Illustrations are simplified, not study results.
What it is
SNAP-8 is a laboratory-made peptide of eight amino acids, sold as a cosmetic ingredient rather than a medicine.
How researchers think it works
Supplier literature proposed interference with a protein complex involved in releasing the signal that makes muscles contract. Independent confirmation in human skin was limited.
What has research seen in people?
The available human data mostly comes from manufacturer testing of finished cosmetic products, reporting measured changes in wrinkle depth.
Independent peer-reviewed trials isolating this peptide were scarce.
Cosmetic testing measures appearance, not biological effect.
Where this material is listed
For laboratory research use only. Not a medicine and not for human or animal use.
Veritide does not sell or supply anything. This links to a third-party UK laboratory supplier; we may earn a commission if you buy through it, at no extra cost to you. Materials are sold for laboratory research use only and are not licensed medicines.
What studies have found
- Most published data came from manufacturer testing of finished cosmetic formulations, reporting changes in measured wrinkle depth.
- Independent peer-reviewed trials isolating this peptide were scarce.
What we still do not know
- Most available data is supplier-funded and not independently replicated.
- Cosmetic ingredient testing measures appearance, not biological effect, and does not establish medicinal action.
Sources
Related profiles
Retatrutide
Triple incretin receptor agonist
An experimental peptide that acts on three hormone receptors. Researchers studied it in phase 2 trials involving weight and blood sugar.
Mazdutide
Dual GLP-1 / glucagon receptor agonist
An experimental peptide based on a natural gut hormone. Researchers studied it mainly in phase 2 and phase 3 trials in China.